Author:
Ohta S.,Kohno M.,Makino Y.,Tachikawa O.,Tasaki Y.,Kikuchi K.,Hirobe M.
Reference16 articles.
1. Barbeau A, Cloutier T, Roy M, Plasse L, Paris S, Poirier J (1985) Ecogenetics of Parkinson’s disease: 4-hydroxylation of debrisoquine. Lancet ii: 1213–1216
2. Gonzalez FJ, Matsunaga T, Nagata K, Meyer UA, Nebert DW, Pastewka J, Kozak CA, Gillette J, Gelboin HV, Hardwick JP (1987) Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. DNA 6: 149–161
3. Kikuchi K, Nagatsu Y, Makino Y, Mashino T, Ohta S, Hirobe M (1991) Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds: 1,2,3,4-tetrahydroisoquinoline (TIQ) and 1 -methyl-1,2,3,4-tetrahydroisoquinoline (1 MeTIQ). Drug Metab Dispos 19: 257–262
4. Kohno M, Ohta S, Hirobe M (1986) Tetrahydroisoquinoline and 1-methyltetrahy- droisoquinoline as novel endogenous amines in rat brain. Biochem Biophys Res Commun 140: 448–454
5. Langston JW, Ballard P, Tetrad JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980